ResMed Inc (RMD): Consensus Target

Corporate company logo of ResMed Inc (RMD)

ResMed Inc. (RMD) revenues rely on the sale of CPAP systems, consumables, and SaaS subscriptions, with margins standing at 272.82. The company is transforming its equipment into a smart environment, leveraging cloud monitoring for remote patient tracking. Low political risks and resilient logistics ensure stability. The price indicator on the chart below illustrates the price action of this specialized medical device manufacturer.

RMD (ResMed) Price Target Chart history from 07/04/2022 to 11/11/2026
Flagship merchandise of ResMed

The consensus forecast represents the average target price from sector analysts, reflecting the aggregate market valuation of the asset's fair value. The stability of the consensus target within the analyst coverage confirms the business's maturity, which for ResMed Inc. (RMD) correlates with the effective implementation of digital technologies in apnea therapy and proficient supply chain management under the leadership of Mick Farrell.

Competing companies

BSX (bostonscientific.com) - Fair Value Consensus|Price Target Chart Edwards Lifesciences Corporation EW|PODD - Consensus Target|Zimmer Biomet Holdings Inc - Analyst Consensus Forecast|COO (CooperSurgical) - Broker Consensus Forecast|Align Technology, Inc. (ALGN) - Price Target Chart|GMED - Analyst Median Target|Price Target Chart transmedics.com|Alphatec Holdings - Forecast Levels Chart|Analyst Consensus Forecast AORT|ENOV - Average Forecast Price|Analyst Consensus Forecast IART (Integra LifeSciences)|ESTA - Consensus Target|Beta Bionics - Analyst Consensus Forecast|Analyst Median Target IRADIMED Corp IRMD|EMBC: Analyst Consensus Forecast|Tandem Corp (TNDM) - Analyst Consensus Forecast|Price Target Chart AxoGen, Inc.|Price Target Chart SIBN|Analyst Consensus Forecast OFIX|Analyst Median Target Bioventus Inc|OrthoPediatrics - Consensus Target|TMCI (Treace Corp) - Forecast Levels Chart|Strata Critical Medical Inc - Analyst Consensus Forecast|Average Forecast Price carlsmed.com|RXST: Analyst Consensus Forecast|Broker Consensus Forecast CLPT|Consensus Target STXS|STIM: Fair Value Consensus|Price Target Chart Sight Sciences, Inc. (SGHT)|Consensus Target Orchestra BioMed Inc. OBIO|Analyst Consensus Forecast ANIK (Anika Therapeutics, Inc.)|InspireMD Inc (NSPR) - Average Forecast Price|Jin Medical International Ltd - Analyst Consensus Forecast|VANI (Vivani Medical, Inc.) - Broker Consensus Forecast|XTNT: Analyst Consensus Forecast|NMTC - Analyst Median Target|MODD (Modular Medical Inc) - Analyst Consensus Forecast|Consensus Target Myomo Inc. (MYO)|Analyst Consensus Forecast COCH|Analyst Consensus Forecast Vivos Therapeutics Inc (VVOS)|Price Target Chart enVVeno Medical NVNO|Sintx Technologies Inc - Price Target Chart|TNON: Consensus Target|Fair Value Consensus LFWD (ReWalk Robotics)|AMIX: Analyst Consensus Forecast|Average Forecast Price INVO Fertility Corp (IVF)|Price Target Chart Bone Biologics|AXNX - Analyst Target Range|Consensus Target BIOL (BIOLASE)|Analyst Consensus Forecast dynatronics.com (DYNT)|Analyst Consensus Forecast FNA (Paragon 28)|Analyst Median Target INVO Bioscience Inc. (INVO)